ACM
GILD icon

AUA Capital Management’s Gilead Sciences GILD Stock Holding History

AUA Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-298
Closed -$22K – 187
2018
Q1 		$22K Sell
298
-100
-25% -$7.95K 0.02% 141
2017
Q4 		$28K Hold
398
– – 0.03% 135
2017
Q3 		$32K Hold
398
– – 0.03% 132
2017
Q2 		$28K Sell
398
-50
-11% -$3.33K 0.03% 138
2017
Q1 		$31K Hold
448
– – 0.03% 121
2016
Q4 		$32K Buy
+448
New +$33.3K 0.03% 128

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AUA Capital Management's GILD Position: Q2 2018 in Review

AUA Capital Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 298 shares — an estimated $22K sold.

AUA Capital Management first reported a position in GILD in Q4 2016 and held it in 6 quarters. The position peaked at $32K in Q3 2017. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • AUA Capital Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • AUA Capital Management sold 298 Gilead Sciences shares in Q2 2018, an estimated $22K.
  • AUA Capital Management first reported a position in Gilead Sciences in Q4 2016 and held it in 6 quarters.
  • AUA Capital Management's Gilead Sciences position peaked at $32K in Q3 2017.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on AUA Capital Management's 13F filing for Q2 2018, filed 10 Jul 2018.